Marcus F. Brackeen

1.1k total citations
16 papers, 651 citations indexed

About

Marcus F. Brackeen is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Marcus F. Brackeen has authored 16 papers receiving a total of 651 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Organic Chemistry and 6 papers in Cellular and Molecular Neuroscience. Recurrent topics in Marcus F. Brackeen's work include Pharmacological Receptor Mechanisms and Effects (4 papers), Neuropeptides and Animal Physiology (4 papers) and Phosphodiesterase function and regulation (4 papers). Marcus F. Brackeen is often cited by papers focused on Pharmacological Receptor Mechanisms and Effects (4 papers), Neuropeptides and Animal Physiology (4 papers) and Phosphodiesterase function and regulation (4 papers). Marcus F. Brackeen collaborates with scholars based in United States and Canada. Marcus F. Brackeen's co-authors include Paul L. Feldman, Joanne Bilotta, H J Leighton, Jeffrey A. Stafford, Donald S. Karanewsky, Les Sekut, J. Alan Menius, Michael W. Lutz, M R Johnson and Michael K. James and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and The Journal of Organic Chemistry.

In The Last Decade

Marcus F. Brackeen

15 papers receiving 607 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marcus F. Brackeen United States 12 253 202 176 107 87 16 651
William B. Wastila United States 13 225 0.9× 43 0.2× 179 1.0× 115 1.1× 63 0.7× 28 589
M. Matsushita Japan 14 142 0.6× 79 0.4× 18 0.1× 98 0.9× 87 1.0× 22 512
Margarete M. Trachez Brazil 12 118 0.5× 44 0.2× 61 0.3× 92 0.9× 31 0.4× 31 360
F. Caussade France 11 104 0.4× 89 0.4× 37 0.2× 49 0.5× 101 1.2× 19 452
A. Cloarec France 9 92 0.4× 126 0.6× 26 0.1× 49 0.5× 88 1.0× 18 440
Spencer C. Yost United States 8 262 1.0× 13 0.1× 47 0.3× 50 0.5× 30 0.3× 9 662
Manabu Suno Japan 12 158 0.6× 17 0.1× 29 0.2× 103 1.0× 48 0.6× 42 606
Steven A. Buckner United States 19 434 1.7× 251 1.2× 7 0.0× 30 0.3× 65 0.7× 57 986
Virginie Licker Switzerland 8 452 1.8× 33 0.2× 76 0.4× 50 0.5× 13 0.1× 8 888
Allen W. Gomoll United States 12 165 0.7× 50 0.2× 9 0.1× 37 0.3× 60 0.7× 38 558

Countries citing papers authored by Marcus F. Brackeen

Since Specialization
Citations

This map shows the geographic impact of Marcus F. Brackeen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcus F. Brackeen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcus F. Brackeen more than expected).

Fields of papers citing papers by Marcus F. Brackeen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcus F. Brackeen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcus F. Brackeen. The network helps show where Marcus F. Brackeen may publish in the future.

Co-authorship network of co-authors of Marcus F. Brackeen

This figure shows the co-authorship network connecting the top 25 collaborators of Marcus F. Brackeen. A scholar is included among the top collaborators of Marcus F. Brackeen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcus F. Brackeen. Marcus F. Brackeen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Brackeen, Marcus F., Bruce E. Blough, Subhakar Dey, et al.. (2025). Two doses of Qβ virus like particle vaccines elicit protective antibodies against heroin and fentanyl. npj Vaccines. 10(1). 57–57.
2.
Wiley, Jenny L., Julie A. Marusich, Bruce E. Blough, et al.. (2024). Evaluation of cannabimimetic effects of selected minor cannabinoids and Terpenoids in mice. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 132. 110984–110984. 2 indexed citations
3.
Decker, Ann M., Marcus F. Brackeen, Chad M. Kormos, et al.. (2022). Identification of a Potent Human Trace Amine-Associated Receptor 1 Antagonist. ACS Chemical Neuroscience. 13(7). 1082–1095. 11 indexed citations
4.
6.
Brackeen, Marcus F., David J. Cowan, Jeffrey A. Stafford, et al.. (1995). Design and Synthesis of Conformationally Constrained Analogs of 4-(3-Butoxy-4-methoxybenzyl)imidazolidin-2-one (Ro 20-1724) as Potent Inhibitors of cAMP-Specific Phosphodiesterase. Journal of Medicinal Chemistry. 38(24). 4848–4854. 35 indexed citations
8.
Feldman, Paul L., Marcus F. Brackeen, David J. Cowan, et al.. (1995). Phosphodiesterase Type IV Inhibition. Structure-Activity Relationships of 1,3-Disubstituted Pyrrolidines. Journal of Medicinal Chemistry. 38(9). 1505–1510. 16 indexed citations
9.
Sekut, Les, et al.. (1995). Anti-inflammatory activity of phosphodiesterase (PDE)-IV inhibitors in acute and chronic models of inflammation. Clinical & Experimental Immunology. 100(1). 126–132. 110 indexed citations
10.
Sekut, Les, J. Alan Menius, Marcus F. Brackeen, & Kevin Connolly. (1994). Evaluation of the significance of elevated levels of systemic and localized tumor necrosis factor in different animal models of inflammation.. PubMed. 124(6). 813–20. 33 indexed citations
11.
Lutz, Michael W., Paul H. Morgan, Michael K. James, et al.. (1994). A pharmacodynamic model to investigate the structure-activity profile of a series of novel opioid analgesics.. Journal of Pharmacology and Experimental Therapeutics. 271(2). 795–803. 3 indexed citations
12.
Brackeen, Marcus F., Jeffrey A. Stafford, Paul L. Feldman, & Donald S. Karanewsky. (1994). An efficient and mild synthesis of highly substituted imidazoles. Tetrahedron Letters. 35(11). 1635–1638. 31 indexed citations
13.
Stafford, Jeffrey A., et al.. (1993). A highly selective protocol for the deprotection of BOC-protected amides and carbamates. Tetrahedron Letters. 34(49). 7873–7876. 75 indexed citations
14.
James, Michael K., et al.. (1991). Opioid receptor activity of GI 87084B, a novel ultra-short acting analgesic, in isolated tissues.. Journal of Pharmacology and Experimental Therapeutics. 259(2). 712–718. 95 indexed citations
15.
Feldman, Paul L., Marcus F. Brackeen, Joanne Bilotta, et al.. (1991). Design, synthesis, and pharmacological evaluation of ultrashort- to long-acting opioid analgesics. Journal of Medicinal Chemistry. 34(7). 2202–2208. 171 indexed citations
16.
Feldman, Paul L. & Marcus F. Brackeen. (1990). A novel route to the 4-anilido-4-(methoxycarbonyl)piperidine class of analgetics. The Journal of Organic Chemistry. 55(13). 4207–4209. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026